{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:47:05Z","timestamp":1784544425382,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.humpath.2026.106176","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:30:20Z","timestamp":1780122620000},"page":"106176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optical genome mapping in myeloid neoplasms"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-4806","authenticated-orcid":false,"given":"Guilin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying S.","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokce A.","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.humpath.2026.106176_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of Myeloid Neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2026.106176_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.humpath.2026.106176_bib3","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib4","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmoldx.2022.09.009","article-title":"Clinical validation and diagnostic utility of optical genome mapping for enhanced cytogenomic analysis of hematological neoplasms","volume":"24","author":"Sahajpal","year":"2022","journal-title":"J Mol Diagn"},{"issue":"4","key":"10.1016\/j.humpath.2026.106176_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajh.27175","article-title":"A framework for the clinical implementation of optical genome mapping in hematologic malignancies","volume":"99","author":"Levy","year":"2024","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106176_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091436","article-title":"Clinical utility of optical genome mapping as an additional tool in a standard cytogenetic workup in hematological malignancies","volume":"17","author":"Toruner","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.humpath.2026.106176_bib9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/ajh.27435","article-title":"Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia","volume":"99","author":"Loghavi","year":"2024","journal-title":"Am J Hematol"},{"issue":"24","key":"10.1016\/j.humpath.2026.106176_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244193","article-title":"Detection of KMT2A partial tandem duplication by optical genome mapping in myeloid neoplasms: associated cytogenetics, gene mutations, treatment responses, and patient outcomes","volume":"16","author":"Wei","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.27575","article-title":"Chromoanagenesis is frequently associated with highly complex Karyotypes, extensive clonal heterogeneity, and treatment refractoriness in acute Myeloid leukemia","volume":"100","author":"Wei","year":"2025","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106176_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","article-title":"Optical genome mapping in acute myeloid leukemia: a multicenter evaluation","volume":"7","author":"Levy","year":"2023","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.humpath.2026.106176_bib13","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.humpath.2026.106176_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41408-022-00718-1","article-title":"Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS\/AML patients","volume":"12","author":"Balducci","year":"2022","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.humpath.2026.106176_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/bjh.70349","article-title":"Optical genome mapping detects cryptic high-risk and targetable abnormalities in adult AML","volume":"208","author":"Bidet","year":"2026","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib16","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.33942","article-title":"Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML\/MDS patients","volume":"150","author":"Gerding","year":"2022","journal-title":"Int J Cancer"},{"issue":"21","key":"10.1016\/j.humpath.2026.106176_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213458","article-title":"Comparative analysis of targeted RNA-Seq and optical genome mapping for detecting gene rearrangements in acute leukemia","volume":"17","author":"Ok","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106176_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2026.106057","article-title":"Acute leukemia with BCL11B rearrangements: genetic landscape, BCL11B expression, and therapeutic response","volume":"171","author":"Tang","year":"2026","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib19","article-title":"Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AML","volume":"10","author":"Torres-Hernandez","year":"2026","journal-title":"npj Precis Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.70024","article-title":"Structural variant analysis of complex karyotype myelodysplastic Neoplasia through optical genome mapping","volume":"64","author":"Valkama","year":"2025","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.humpath.2026.106176_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100862","article-title":"Optical genome mapping in myelodysplastic syndromes: clinical value and limitations derived from a cohort of 236 patients","volume":"38","author":"Wei","year":"2025","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib22","first-page":"1130","article-title":"Acute myeloid leukemia with t(10;17)(p15;q21)\/ZMYND11::MBTD1: a subtype with minimal differentiation, CD7\/CD56 expression, and generally poor outcomes in adults","volume":"111","author":"Wei","year":"2026","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2026.106176_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jmoldx.2026.01.002","article-title":"Technical validation and prospective clinical utility of optical genome mapping in acute leukemia workup: insights from 200 cases following deployment as a first-line diagnostic test in a tertiary care center","volume":"28","author":"Parlow","year":"2026","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123263","article-title":"Analytic validation of optical genome mapping in hematological malignancies","volume":"11","author":"Pang","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.humpath.2026.106176_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jmoldx.2025.12.006","article-title":"Copy-neutral loss of heterozygosity in myelofibrosis: parallel evaluation with optical genome mapping and single-nucleotide polymorphism arrays","volume":"28","author":"Diaz-Gonzalez","year":"2026","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125763","article-title":"Application of optical genome mapping for the diagnosis and risk stratification of Myeloid and lymphoid malignancies","volume":"26","author":"Ballesta-Alcaraz","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123214","article-title":"Clinical utility of optical genome mapping and 523-Gene next generation sequencing panel for comprehensive evaluation of Myeloid cancers","volume":"15","author":"Sahajpal","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.humpath.2026.106176_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072131","article-title":"Optical genome mapping in routine cytogenetic diagnosis of acute leukemia","volume":"15","author":"Soler","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.humpath.2026.106176_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092058","article-title":"Optical genome mapping as a diagnostic tool in pediatric acute Myeloid leukemia","volume":"14","author":"Suttorp","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.humpath.2026.106176_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/bloodadvances.2025017980","article-title":"Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling","volume":"10","author":"Diaz-Gonzalez","year":"2026","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100937","article-title":"Optical genome mapping in pediatric hematologic malignancies: high diagnostic yield and unique insights across leukemia subtypes","volume":"39","author":"Smith","year":"2026","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13039-025-00733-4","article-title":"Rare case of PLAG1::RUNX1 fusion mimicking classical t(8;21): the value of optical genome mapping in acute myeloid leukemia","volume":"18","author":"Assaf","year":"2025","journal-title":"Mol Cytogenet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13039-025-00744-1","article-title":"Optical genome mapping identifies novel ENOX2::RUNX1 t(X;21)(q26.1;q22.12) rearrangement in acute myeloid leukemia-myelodysplasia related: first case report","volume":"19","author":"George","year":"2025","journal-title":"Mol Cytogenet"},{"issue":"6","key":"10.1016\/j.humpath.2026.106176_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061684","article-title":"Optical genome mapping for cytogenetic diagnostics in AML","volume":"15","author":"Nilius-Eliliwi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.humpath.2026.106176_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/genes15111402","article-title":"Optical genome mapping reveals complex and cryptic rearrangement involving PML::RARA fusion in acute promyelocytic leukemia","volume":"15","author":"Klausner","year":"2024","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/genes16010007","article-title":"Utilization of RT-PCR and optical genome mapping in acute promyelocytic leukemia with cryptic PML::RARA rearrangement: a case discussion and systemic literature review","volume":"16","author":"George","year":"2024","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.humpath.2026.106176_bib37","article-title":"A case of cryptic CBFB::MYH11 acute Myeloid leukemia with noncanonical breakpoints detected by optical genome mapping","volume":"23","author":"Edelman Saul","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/genes16030317","article-title":"Cryptic KMT2A::AFDN fusion due to AFDN insertion into KMT2A in a patient with acute monoblastic leukemia","volume":"16","author":"Wei","year":"2025","journal-title":"Genes"},{"issue":"24","key":"10.1016\/j.humpath.2026.106176_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244171","article-title":"Unveiling the complexity of KMT2A rearrangements in acute Myeloid leukemias with optical genome mapping","volume":"16","author":"Lacoste","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.humpath.2026.106176_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112942","article-title":"Novel NUP98::ASH1L gene fusion in acute Myeloid leukemia detected by optical genome mapping","volume":"15","author":"Tembrink","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9936","key":"10.1016\/j.humpath.2026.106176_bib41","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","article-title":"Myelodysplastic syndromes","volume":"383","author":"Ades","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.humpath.2026.106176_bib42","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/cncr.23977","article-title":"Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities","volume":"113","author":"Pozdnyakova","year":"2008","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.humpath.2026.106176_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15113039","article-title":"Cytogenetic assessment and risk stratification in myelofibrosis with optical genome mapping","volume":"15","author":"Diaz-Gonzalez","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.humpath.2026.106176_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ajh.23751","article-title":"Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution","volume":"89","author":"Tang","year":"2014","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ajh.26455","article-title":"Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Patnaik","year":"2022","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","article-title":"Cytogenetic risk stratification in chronic myelomonocytic leukemia","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.humpath.2026.106176_bib47","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/nm.2988","article-title":"Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements","volume":"18","author":"Holland","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2026.106176_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13039-019-0415-7","article-title":"Chromoanagenesis: cataclysms behind complex chromosomal rearrangements","volume":"12","author":"Pellestor","year":"2019","journal-title":"Mol Cytogenet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106176_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/gcc.10219","article-title":"Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia","volume":"37","author":"Steudel","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.humpath.2026.106176_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.leu.2402352","article-title":"Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23","volume":"16","author":"Shiah","year":"2002","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.humpath.2026.106176_bib52","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/leu.2010.124","article-title":"Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML","volume":"24","author":"Dicker","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.humpath.2026.106176_bib53","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06301.x","article-title":"The MLL partial tandem duplication in acute myeloid leukaemia","volume":"135","author":"Basecke","year":"2006","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106176_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16091693","article-title":"Genomic characterization of partial tandem duplication involving the KMT2A gene in adult acute Myeloid leukemia","volume":"16","author":"Seto","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.humpath.2026.106176_bib55","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/leu.2016.196","article-title":"Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2","volume":"30","author":"Eisfeld","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2026.106176_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062376","article-title":"Prognostic significance of KMT2A-PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis","volume":"13","author":"Ye","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.humpath.2026.106176_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cancergen.2019.03.002","article-title":"Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations","volume":"233\u2013234","author":"Tang","year":"2019","journal-title":"Cancer Genet"},{"issue":"2","key":"10.1016\/j.humpath.2026.106176_bib58","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood.2019003701","article-title":"Atypical 3q26\/MECOM rearrangements genocopy inv(3)\/t(3;3) in acute myeloid leukemia","volume":"136","author":"Ottema","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2026.106176_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020458","article-title":"3q26.2\/MECOM rearrangements by pericentric Inv(3): diagnostic challenges and clinicopathologic features","volume":"15","author":"Tang","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2016.267","article-title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis","volume":"31","author":"Struski","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.humpath.2026.106176_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41375-025-02848-4","article-title":"NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners","volume":"40","author":"Chonabayashi","year":"2026","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.humpath.2026.106176_bib62","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood.2020007093","article-title":"Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies","volume":"136","author":"Michmerhuizen","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2026.106176_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3324\/haematol.2019.236745","article-title":"The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia","volume":"106","author":"Noort","year":"2021","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.humpath.2026.106176_bib64","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2026.106176_bib65","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41436-019-0545-7","volume":"21","author":"Mikhail","year":"2019","journal-title":"Genet Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:18:29Z","timestamp":1781065109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":65,"alternative-id":["S0046817726001450"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106176","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical genome mapping in myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106176"}}